
Supernova Pharmaceuticals Private Limited
Trading chemical and pharmaceutical products since 2016, with registered office in Delhi.
Trading chemical and pharmaceutical products since 2016, with registered office in Delhi.
Supernova Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 August 2016 (Eight years and eight months 26 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rahul Malik, Amardeep Kaur, Mohan Rawat, and Three other members serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U74999DL2016PTC304616
304616
Private Limited Indian Non-Government Company
18 Aug 2016
30 Sep 2019
31 Mar 2019
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rahul Malik ![]() | Director | 17-Feb-2021 | Current |
Amardeep Kaur ![]() | Director | 17-Feb-2021 | Current |
Mohan Rawat ![]() | Director | 24-Nov-2018 | Current |
Om Tanwar ![]() | Director | 17-Feb-2021 | Current |
Rukmani ![]() | Director | 24-Nov-2018 | Current |
Devi Dayal ![]() | Director | 24-Nov-2018 | Current |
Supernova Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 120.24% increase. The company also saw a substantial fall in profitability, with a 2925.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.78%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Supernova Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Rahul Malik is a mutual person
Rahul Malik is a mutual person
Rahul Malik and Amardeep Kaur are mutual person
Rahul Malik, Amardeep Kaur and 1 more are mutual person
Amardeep Kaur is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Supernova Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Supernova Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supernova Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rahul Malik was appointed as a Director was appointed as a Director on 17 Feb 2021 & has been associated with this company since 4 years 2 months .
Amardeep Kaur was appointed as a Director was appointed as a Director on 17 Feb 2021 & has been associated with this company since 4 years 2 months .
Om Prakash Tanwar was appointed as a Director was appointed as a Director on 17 Feb 2021 & has been associated with this company since 4 years 2 months .
Supernova Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Supernova Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi.
Mohan Singh Rawat was appointed as a Director was appointed as a Director on 24 Nov 2018 & has been associated with this company since 6 years 5 months .
Supernova Pharmaceuticals Private Limited was incorporated on 18 Aug 2016.
The authorized share capital of Supernova Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.50 M.
Currently 6 directors are associated with Supernova Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Supernova Pharmaceuticals Private Limited is B-11 Somdutt Chamber –Ii, Bhikaji Cama Place - India, New Delhi, 110066.
The corporate identification number (CIN) of Supernova Pharmaceuticals Private Limited is U74999DL2016PTC304616 and the company number is 304616 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2019, the revenue trend for Supernova Pharmaceuticals Private Limited has risen by 120.24%.
The financial reports for the fiscal year 2019 indicates that The net worth of Supernova Pharmaceuticals Private Limited has experienced an downturn of -14.78%.
The most recent Balance Sheet for Supernova Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2019.
Search company & director profiles for free and gain access to critical business data.
AS
RS
AC
RM
NK